| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CYP4B1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | CD27 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | CHPT1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | NR1D2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | STX2 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | YPEL2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | EMB | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | RIDA | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | NPAP1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | CXorf21 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
